• Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

  • Jul 25 2024
  • Length: 28 mins
  • Podcast

Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy  By  cover art

Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

  • Summary

  • In this episode of Conversations in Drug Development, host Harriet Edwards is joined by two regulatory experts from Boyds, Dr Patrick Ginty and Monica Pianella, to discuss cell-based immunotherapies, focusing on CAR-T cells and TCR-T cells.

    Patrick and Monica delve into these cutting-edge treatments, discussing their uses, the complexities of their production, and important safety considerations. They also highlight recent advancements and the exciting future prospects for these therapies in cancer treatment and other areas.

    Tune in for an insightful discussion on the future of cell-based immunotherapies, examining both the hurdles and the potential of these innovative treatments.

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.